AOC3 and subarachnoid hemorrhage: VAP-1 blockade with an SSAO inhibitor also reduces the neurological consequences of subarachnoid hemorrhage by attenuating leukocyte trafficking to the site of insult and pial arteriolar reactivity to dilatory signals (138, 139).